EUVIMEDEUVIMED entdecken
Crossref

Inhibition of mitochondrial NADH :ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells

Shashank Hambarde, Arvind Pandey, David S Baskin, Santosh A Helekar iD

FEBS Letters · 2026

DOI: 10.1002/1873-3468.70271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2026. Verfasst von Shashank Hambarde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research, Houston Methodist Hospital, TX, USA. Hauptthemen laut MEDLINE: Mitochondria, Magnetic Fields, Electron Transport Complex I, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Donna and Kenneth R. Peak, Kenneth R. Peak Foundation, John S. Dunn Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A newly developed noninvasive Oncomagnetic device (OMD) causes selective cytotoxicity in glioblastoma and diffuse intrinsic pontine glioma cells, providing a novel, non‐toxic approach to anticancer therapy. Here, we report results in cultured glioma cells and in a syngeneic mouse model indicating that the immediate intracellular target mechanism of action of the spinning oscillating magnetic field (sOMF) produced by this device is reactive oxygen species‐dependent persistent inhibition of mitochondrial complex I. Steps downstream of this mechanism involve the production of oxidative stress, DNA damage, G1 phase cell cycle arrest, and caspase‐dependent apoptosis. We also show that sOMF does not produce these effects in normal human astrocytes and astroglial cells. These data provide a rationale for safe clinical use of OMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaMagnetic FieldsElectron Transport Complex IGliomaAnimalsHumansMiceReactive Oxygen SpeciesApoptosisCell Line, TumorDNA DamageAstrocytesOxidative Stress

Stichwörter der Autor:innen

DNA damagebrain tumorcomplex I inhibitionmagnetic therapy

Substanzen

Reactive Oxygen SpeciesElectron Transport Complex I

Autor:innen und Institutionen

  • Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment and Research, Houston Methodist Hospital, TX, USA.
  • Department of Neurosurgery, Houston Methodist Hospital, TX, USA.
  • Houston Methodist Academic Institute, TX, USA.
  • Translational Biomagnetics and Neurometry Program, Houston Methodist Research Institute, TX, USA.
  • Weill Cornell Medical College, New York, NY, USA.
  • Texas A & M Medical School, College Station, TX, USA.

ORCID-Profile: Santosh A Helekar

Förderung

  • Donna and Kenneth R. Peak
  • Kenneth R. Peak Foundation
  • John S. Dunn Foundation
  • The Methodist Hospital Foundation
  • Blanche Green Fund of the Pauline Sterne Wolff Memorial Foundation
  • Veralan Foundation
  • Taub Foundation
  • Translational Research Initiative of the Houston Methodist Research Institute

Zitieren

APA

Hambarde, S., Pandey, A., Baskin, D. S., & Helekar, S. A. (2026). Inhibition of mitochondrial NADH :ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells. FEBS Letters. https://doi.org/10.1002/1873-3468.70271

Vancouver

Hambarde S, Pandey A, Baskin DS, Helekar SA. Inhibition of mitochondrial NADH :ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells. FEBS Letters. 2026. doi:10.1002/1873-3468.70271

BibTeX
@article{Hambarde2026,
  author = {Hambarde, Shashank and Pandey, Arvind and Baskin, David S and Helekar, Santosh A},
  title = {Inhibition of mitochondrial NADH :ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells},
  journal = {FEBS Letters},
  year = {2026},
  doi = {10.1002/1873-3468.70271}
}
Kostenlos starten →